Apellis Pharmaceuticals, Inc.

APLSNasdaq· Pharmaceutical Preparations

Price History

Revenue

$1.0B

▲ 28.5% YoY

Net Income

$22.4M

▲ 111.3% YoY

EPS

$0.20

▲ 112.5% YoY

Cash

$466.2M

▲ 13.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.